tiprankstipranks
Takeda Reports Impressive Profit Growth Amid Revenue Rise
PremiumCompany AnnouncementsTakeda Reports Impressive Profit Growth Amid Revenue Rise
26d ago
Takeda Pharmaceutical Raises FY2024 Financial Forecast
Premium
Company Announcements
Takeda Pharmaceutical Raises FY2024 Financial Forecast
26d ago
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
Premium
The Fly
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
1M ago
Firefly Neuroscience collaborates with Takeda, Novartis
PremiumThe FlyFirefly Neuroscience collaborates with Takeda, Novartis
2M ago
Takeda receives European Commission approval for ADZYNMA
Premium
The Fly
Takeda receives European Commission approval for ADZYNMA
4M ago
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
Premium
The Fly
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
4M ago
Takeda Pharmaceutical Annual Financial Overview
PremiumCompany AnnouncementsTakeda Pharmaceutical Annual Financial Overview
5M ago
Takeda Reinforces Governance with New Director Roles
Premium
Company Announcements
Takeda Reinforces Governance with New Director Roles
5M ago
Takeda: Japanese MHLW approves LIVTENCITY
Premium
The Fly
Takeda: Japanese MHLW approves LIVTENCITY
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100